Guangdong Longchuangji Pharmaceutical Co., Ltd.
Clinical trials sponsored by Guangdong Longchuangji Pharmaceutical Co., Ltd., explained in plain language.
-
Could probiotics cure a common vaginal infection?
Disease control CompletedThis study tested whether vaginal capsules containing two types of lactobacillus (good bacteria) can treat bacterial vaginosis, a common infection. Sixty-six women aged 18 to 50 took part. The goal was to see if the probiotics could restore normal vaginal health better than a pla…
Phase: PHASE2 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 24, 2026 04:18 UTC
-
Good bacteria capsules aim to tame vaginal infection
Disease control CompletedThis study tested whether vaginal capsules containing two types of live 'good' bacteria (lactobacilli) are safe and tolerable for treating bacterial vaginosis (BV), a common vaginal infection. Fifty-seven women with BV took part and received either the lactobacilli capsules or a …
Phase: PHASE2 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
Probiotic capsules take on bacterial vaginosis in major trial
Disease control CompletedThis study tested whether vaginal probiotic capsules can cure bacterial vaginosis (BV) better than a placebo. 402 women with BV took part. The main goal was to see if more women were cured 21-30 days after treatment with the probiotic compared to placebo. The trial was completed …
Phase: PHASE3 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 05, 2026 12:08 UTC